Total US retinal procedure volume topped an estimated 1.1 million in Q3-2012, but the rate
of growth for IVT treatments failed to keep pace with previous quarters.
Our latest quarterly glaucoma survey indicates a significant increase in the use of the Alcon ExPress, Glaukos iStent, and other alternatives to conventional filtering surgery during the quarter.
The market for photocoagulation, photodisruptor, and SLT lasers is lucrative,
with sales estimated at more than $345 million in 2012.
A federal appeals court has added more confusion to the process of off-label drug use by ruling that pharmaceutical companies and their employees can’t be prosecuted for promoting drugs for unapproved uses.
You are not currently logged in.
©2017 Market Scope
Lost your Password